Loading ......
Human Papillomavirus (HPV) is a highly prevalent group of viruses that can infect skin and mucosal surfaces. With over 200 different types, HPV is categorized into low-risk and high-risk groups based on their potential to cause cancer. Low-risk types, such as HPV-6 and HPV-11, are primarily associated with benign conditions like anogenital warts. In contrast, high-risk types, including HPV-16, HPV-18, and others, are the primary cause of cervical, anal, oropharyngeal, and other anogenital cancers.The Human Papilloma-Specific IgG ELISA Kit is a crucial diagnostic tool that offers a sensitive and specific method for the quantitative or semi-quantitative detection of these antibodies.
Figure 1. Human Papillomavirus (HPV).
Unlike measles or varicella virus, HPV infection has its own characteristics:

Localized infection: HPV infection is strictly limited to the epithelial cells of the skin and mucous membranes, and the virus does not enter the bloodstream.
Weak serological response: Limited exposure to viral antigens results in only about 50-70% of infected individuals producing detectable serum antibodies, and antibody levels are typically low.
Type specificity: The antibody response has high type specif icity, meaning that antibodies against HPV 16 do not neutralize HPV 18. Therefore, detection must be targeted at specific types.
The importance of conformational epitopes: The most critical neutralizing antibody epitope is located on the conformational spatial structure formed by L1 protein assembly. Only antigens that can maintain this three-dimensional structure, such as VLPs, can effectively detect antibodies with neutralizing activity.Technology Platform
Sample Type Compatibility
Sensitivity Profile
Kit Features
Performance Characteristics
Interpretation of Results and Determination of Cut off
Sample Requirements
Data Calculation

Assessment of Vaccine Efficacy
The primary application of this ELISA kit is to evaluate the serological response to HPV vaccination. The current HPV vaccines are based on VLPs of specific high-risk types (e.g., HPV-16, HPV-18) and low-risk types (e.g., HPV-6, HPV-11). Measuring antibody titers post-vaccination provides a key metric of a successful immune response.

Epidemiological and Seroprevalence Studies
Serological testing is an invaluable tool for conducting large-scale epidemiological studies to determine the prevalence of past HPV exposure within a population. Unlike DNA tests, which detect current infection, an antibody test can provide insight into cumulative exposure over an individual's lifetime.
| Parameter | Details |
| Product name | Human Papilloma Virus IgG ELISA kit |
| Sample | plasma, serum |
| Intended Use | Enzyme Immuno Assay (EIA) for determination of IgG class antibodies to Human Papilloma Virus (or HPV) in human plasma and sera. The product is supplied for research purpose only. It is not for use in the diagnosis or for the follow-up of patients administered with the vaccines containing HPV antigens. |
| Storage | 2°C to 8°C |
In conclusion, the Human Papilloma-Specific IgG ELISA Kit is a state-of-the-art tool that provides invaluable insight into an individual's or a population's immune status against HPV. By complementing traditional HPV DNA testing, this serological assay enhances our ability to monitor vaccination programs, conduct large-scale epidemiological studies, and better understand the complex dynamics of HPV infection and immunity. Its role in both clinical research and public health is undeniable, contributing significantly to our global efforts to prevent and control HPV-related diseases.
I can't. Whether it is natural infection or vaccination with VLP vaccine, the antibodies produced are specific to VLP, and this kit cannot distinguish their sources.
This is quite common. The reasons include: ①The antibodies have not been produced in the early stage of infection; ② Individual immune response is weak and fails to produce detectable antibody levels; ③ The antibodies have decayed below the detection limit after a previous infection.
Absolutely not recommended. Each type must be tested separately. Mixing different types of VLPs can introduce competitive binding, leading to decreased sensitivity and unreliable results.
Loading ......